Skip to main content
SpringerLink
Log in

The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy

  • Review Article
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The present article reviews the role of the second messenger enzyme protein kinase C (PKC) in the growth regulation of high-grade gliomas, and evaluates the efficacy of therapeutic strategies directed against PKC for blocking the proliferation of these malignancies in in vitro and in vivo models. The translation of such strategies to the treatment of patients with malignant gliomas may provide a novel approach for improving the otherwise grim outlook associated with these neoplasms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aaronson SA (1991) Growth factors and cancer. Science 254: 1146–1153

    PubMed  Google Scholar 

  2. Adler V, Polotskaya A, Wagner F, Kraft AS (1992) Affinity-purified c-jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem 267: 17001–17005

    PubMed  Google Scholar 

  3. Aflalo E, Wolfson M, Ofir R, Weinstein Y (1992) Elevated activities of protein kinase C and tyrosine kinase correlate to leukemic cell aggressiveness. Int J Cancer 50: 136–141

    PubMed  Google Scholar 

  4. Ahmad S, Mineta T, Martuza RL, Glazer RI (1994) Anti-sense expression of protein kinase C-alpha inhibits the growth and tumourigenicity of human glioblastoma cells. Neurosurgery 35: 904–909

    PubMed  Google Scholar 

  5. Akinaga S, Akiyama T, Shimizu M, Okabe M (1996) G1 phase accumulation induced UCN-01 is associated with dephosphorylation of Rb and cdk-2, as well as induction of cdk inhibitor p21 in p53-mutated human carcinoma cells. Proc Annu Meet Am Assoc Cancer Res 37: A2888

    Google Scholar 

  6. Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M (1991) Antitumour activity of UCN-01, a selective inhibotor of protein kinase C, in murine and human tumour models. Cancer Res 51: 4888–4892

    PubMed  Google Scholar 

  7. Akinaga S, Nomura K, Gomi K, Ikabe M (1993) Enhancement of antitumour activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C. Cancer Chemother Pharmacol 32: 183–189

    PubMed  Google Scholar 

  8. Akinaga S, Nomura K, Gomi K, Okabe M (1994) Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid ccarcimoma, A431 cells. Cancer Chemother Pharmacol 33: 273–280

    PubMed  Google Scholar 

  9. Alvaro V, Touraine PH, Vozari RR, Bai-Grenier F, Birman P, Joubert (Bression) D (1992) Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer 50: 724–730

    PubMed  Google Scholar 

  10. Baltuch GH, Couldwell WT, Villemure JG, Yong VW (1993) Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33: 495–501

    PubMed  Google Scholar 

  11. Baltuch GH, Dooley NP, Couldwell WT, Yong VW (1993) Staurosporine differentially inhibits glioma versus non-glioma cell lines. J Neurooncol 16: 141–147

    PubMed  Google Scholar 

  12. Baltuch GH, Dooley NP, Rostworowski KM, Villemure J-G, Yong VW (1995) Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation. J Neurooncol 24: 241–250

    PubMed  Google Scholar 

  13. Baltuch GH, Dooley NP, Villemure JG, Yong VW (1995) Protein kinase C and growth regulation of malignant gliomas. Can J Neurol Sci 22: 264–271

    PubMed  Google Scholar 

  14. Baltuch GH, Shenouda G, Langleben A, Villemure J-G (1993) High dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regession. Can J Neurol Sci 20: 168–170

    PubMed  Google Scholar 

  15. Baltuch GH, Yong VW (1996) Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway. Brain Res 710: 143–149.

    PubMed  Google Scholar 

  16. Basu A (1993) The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther 59: 257–280

    PubMed  Google Scholar 

  17. Basu A, Kozikowski AP, Sato K, Lazo JS (1991) Cellular sensitization to cis-diamminedichloroplatinum (II) by novel analogues of protein kinase C activator lyngbyatoxin A. Cancer Res 51: 2511–2514

    PubMed  Google Scholar 

  18. Basu A, Lazo JS (1992) Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum (II) by bryostatin 1. Cancer Res 52: 3119–3124

    PubMed  Google Scholar 

  19. Basu A, Lazo JS (1994) Protein kinase C In: Kerr DJ, Workman J (eds) New molecular targets for cancer chemotherapy. CRC, Boca Raton, pp 121–141

    Google Scholar 

  20. Basu A, Teicher BA, Lazo JS (1990) Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum (II). J Biol Chem 265: 8541–8547

    Google Scholar 

  21. Begemann M, Kashimawo SA, Choi YJA, Kim S, Christiansen KM, Duigou G, Mueller M, Schieren I, Ghosh S, Fabbro D, Lampen NM, Heitjan DF, Schiff PB, Bruce JN, Weinstein IB (1996) Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumour promotor. Clin Cancer Res 2: 1017–1030

    PubMed  Google Scholar 

  22. Bell RM, Burns DJ (1991) Lipid activation of protein kinase C. J Biol Chem 266: 4661–4664

    PubMed  Google Scholar 

  23. Benzil DL, Finkenstein SD, Epstein MH, Finch PW (1992) Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res 52: 2951–2956

    PubMed  Google Scholar 

  24. Berridge MJ, Irvine RF (1994) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315–321

    Google Scholar 

  25. Bhat NR (1989) Role of protein kinase C in glial proliferation. J Neurosci Res 22: 20–27

    PubMed  Google Scholar 

  26. Bigner SH, Mark J, Burger PC, Mahaley SM, Bullard DEJ, Muhlbaier LH, Bigner DD (1988) Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48: 405–411

    PubMed  Google Scholar 

  27. Billah MM, Anthes JC (1990) The regulation and cellular functions of phosphatidylcholine hydrolysiis. Biochem J 269: 281–291

    PubMed  Google Scholar 

  28. Blenis J (1993) Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90: 5889–5892

    PubMed  Google Scholar 

  29. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA (1993) Selective regulation of expression of protein kinase C (PKC) isoenzymes in multi-drug resistant MCF-7 cells. J Biol Chem 268: 658–664

    PubMed  Google Scholar 

  30. Blumberg PM (1988) Protein kinase C as the receptor for the phorbol ester tumour promoters. Cancer Res 48: 1–8

    PubMed  Google Scholar 

  31. Bogler O, Huang H-J SU, Kleihues P, Cavenee WK (1995) The p53 gene and its role in human brain tumours. GLIA 15: 308–327

    PubMed  Google Scholar 

  32. Boutwell RK (1974) The function and mechanism of promotors of carcinogenesis. Crit Rev Toxicol 2: 419–433

    Google Scholar 

  33. Brandt SJ, Niedel JE, Bell RM,et al (1987) Distinct patterns of expression of different protein kinase C mRNAs in rat tissue. Cell 49: 57–63

    PubMed  Google Scholar 

  34. Bredel M, Pollack IF, Freund JM, Sebti SM (1997) p21Ras Inhibition as a novel therapeutic strategy for blocking malignant glioma growth. Proceedings of the 11th International Congress of Neurological Surgery, Amsterdam, Netherlands July 6–11, 1997

  35. Bredel M, Pollack IF, Freund JM, Rusnak J, Lazo JS (1997) Induction of apoptosis and growth regulation of malignant gliomas: UCN-01, a selective inhibitor of protein kinase C glioma proliferation in vitro. Proceedings of the 11th International Congress of Neurological Surgery, Amsterdam, Netherlands, July 6–11, 1997

  36. Brondani da Rocha A, Mans DR, Bernard EA, de Lima Lopes G Jr, Schwartsmann G (1996) Inhibition of protein kinase C (PKC) activity by tamoxifen (Tmx) in cultured glioma cells. Proc Annu Meet Am Assoc Cancer Res 37: A2889j

    Google Scholar 

  37. Bunch RT, Eastman A (1996) Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor. Clin Cancer Res 2: 791–797

    PubMed  Google Scholar 

  38. Burger PC, Scheithauer BW, Vogel FS (1991) Surgical pathology of the nervous system and its coverings, 3rd Ed. Churchill Livingstone, New York, pp 194–271

    Google Scholar 

  39. Burns DJ, Bloomenthal J, Lee MH, Bell RM (1990) Expression of the alpha, beta II, and gamma protein kinase C isozymes in the baculovirus-insect cell expression system. Purification and characterization of the individual isoforms. J Biol Chem 265: 12044–12051

    PubMed  Google Scholar 

  40. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB (1993) The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095–2104

    PubMed  Google Scholar 

  41. Chambers TC, Chalikonda I, Eilon G (1990) Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem Biophys Res Commun 169: 253–259

    PubMed  Google Scholar 

  42. Chambers TC, McAvoy EM, Jacobs JW, Eilon G (1990) Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265: 7679–7686

    PubMed  Google Scholar 

  43. Chao T-SO, Foster DA, Rapp UR, Rosner MR (1994) Differential raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbol esters, and calcium. J Biol Chem 269: 7337–7341

    PubMed  Google Scholar 

  44. Chen CC (1993) Protein kinase C alpha, delta, epsilon and zeta in C6 glioma cells. FEBS Lett 332: 169–173

    PubMed  Google Scholar 

  45. Chen CC, Chang J, Lin W (1995) Differential expression of protein kinase C isoforms in glial and neuronal cells. Translocation and down-regulation of PKC isoforms in C6 glioma and NG 108-15 hybrid cells: effects ef extracellular Ca2+-deletion. Neurochem Internat 26: 455–464

    Google Scholar 

  46. Chen CY, Faller DV (1995) Direction of p21Ras generated signals towards cell growth or apoptosis is determined by protein kinase C and bcl-2. Oncogene 11: 1487–1498

    PubMed  Google Scholar 

  47. Chiarugi V, Bruni P, Pasquali F, Magnelli L, Basi G, Ruggiero M, Farnarraro M (1989) Synthesis of diacylglycerol de novo is responsible for permanent activation and down-regulation of protein kinase C in transformed cells. Biochem Biophys Res Commun 164: 816–823

    PubMed  Google Scholar 

  48. Choi PM, Tchou-Wong K-M, Weinstein B (1990) Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumour suppression. Mol Cell Biol 10: 4650–4657

    PubMed  Google Scholar 

  49. Choudhury GG, Sylvia VL, Sakaguchi AY (1991) Activation of a phosphatidylcholine-specific phospholipase C by colony stimulating factor 1 receptor requires tyrosine phosphorylation and a guanine nucleotide-binding protein. J Biol Chem 266: 23147–23151

    PubMed  Google Scholar 

  50. Clark EA, Leach KL, Trojanowski JQ,et al (1991) Characterization and differential distribution of the three major protein kinase C isozymes of the central nervous system in normal and Alzheimer's disease brains. Lab Invest 64: 35–44

    PubMed  Google Scholar 

  51. Colburn NH, Former BF, Nelson KA, Yuspa SH (1979) Tumour promotor induces anchorage independence irreversibly. Nature 281: 589–591

    PubMed  Google Scholar 

  52. Couldwell WT, Antel JP, Apuzzo MLJ, Yong VW (1990) Inhibition of growth of established human glioma cell lines by modulators of the protein kinase C system. J Neurosurg 73: 594–600

    PubMed  Google Scholar 

  53. Couldwell WT, Antel JP, Yong VW (1992) Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31: 717–724

    PubMed  Google Scholar 

  54. Couldwell WT, Hinton DR, Law RE (1994) Protein kinase C and growth regulation in malignant gliomas. Neurosurgery 35: 1184–1186

    PubMed  Google Scholar 

  55. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, Law RE (1994) Protein kinase C inhibitors induce apoptosis in human malignant gioma cell lines. FEBS Lett 345: 43–46

    PubMed  Google Scholar 

  56. Couldwell WT, Hinton DR, Surnock AA, DeGiorgio CM, Weiner LP, Apuzzo MLJ, Masri L, Law RE, Weiss MH (1996) Treatment of recurrent malignant gliomas with chronic oral high-doose tamoxifen. Clin Cancer Res 2: 619–622

    PubMed  Google Scholar 

  57. Couldwell WT, Uhm JH, Antel JP, Yong VW (1991) Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29: 880–887

    PubMed  Google Scholar 

  58. Couldwell WT, Weiss MH, De Giorgio CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS, Apuzzo ML (1993) Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 32: 485–490

    PubMed  Google Scholar 

  59. Deimling A von, Louis DN, Ammon K von, Petersen I, Hoell T, Chung RY, Martuza R, Schoenfeld D, Yaşargil MG, Wiestler OD, Seizinger BR (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 285–301

    Google Scholar 

  60. Deimling A von, Louis DN, Wiestler OD (1995) Molecular pathways in the formation of gliomas. GLIA 15: 328–338

    PubMed  Google Scholar 

  61. Dekker LV, Parker PJ (1994) Protein kinase C — a question of specificity. Trends Biochem Sci 19: 73–77

    PubMed  Google Scholar 

  62. Denmeade SR, Isaacs JT (1996) Programmed cell death (apoptosis) and cancer chemotherapy. Cancer Control 3: 303–309

    PubMed  Google Scholar 

  63. De Vente JE, Kiley S, Garrio T, Bryant W, Hooker J, Posekany K, Parker PJ, Cook P, Fletcher D, Ways DK (1995) Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth Diff 6: 371–382

    PubMed  Google Scholar 

  64. De Vente JE, Kukoly CA, Bryant WO, Posekany KJ, Chen J, Fletcher DJ, Parker PJ, Pettit GJ, Lozano G, Cook PP, Ways DK (1995) Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. J Clin Invest 96: 1874–1886

    PubMed  Google Scholar 

  65. Diaz-Laviada I, Larrodera P, Diaz-Meco MT, Cornet ME, Guddal PH, Johansen T, Moscat J (1990) Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein C by ras and src oncogenes. EMBO J 9: 3907–3912

    PubMed  Google Scholar 

  66. Dive C, Evans CA, Chapman RC, Owen-Lynch PJ, Whetton AD (1994) Signal transduction events for the suppression of apoptosis. Br J Cancer 71: 5

    Google Scholar 

  67. Dooley NP, Baltuch GB, Paton A,et al (1994) Phosphothioate antisense oligonucleotides to protein kinase Cα inhibit proliferation in rat C6 glioma. Proc Annu Meet Am Assoc Cancer Res 35: A 3375

    Google Scholar 

  68. Drieger PE, Blumberg PM (1977) The effect of phorbol esters on chicken embryo fibroblasts. Cancer Res 37: 3257–3265

    PubMed  Google Scholar 

  69. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164–2172

    PubMed  Google Scholar 

  70. Eldar H, Zisman Y, Ullrich A, Livneh E (1990) Overexpression of protein kinase Cα-subtype in swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers of epidermal growth factor. J Biol Chem 265: 13290–13296

    PubMed  Google Scholar 

  71. Evans CA, Lord JM, Owen-Lynch PJ, Johnson G, Dive C, Whetton AD (1995) Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haemopoietic cell line. J Cell Science 108: 2591–2598

    PubMed  Google Scholar 

  72. Evans VG (1993) Multiple pathways to apoptosis. Cell Biol Int 17: 461–476

    PubMed  Google Scholar 

  73. Exton JH (1990) Signaling through posphatidylcholine breakdown. J Biol Chem 265: 1–4

    PubMed  Google Scholar 

  74. Fields AP, Tyler G, Kraft AS, May WS (1990) Role of nuclear protein kinase C in the mitogenic response to platelet-derived growth factor. J Cell Science 96: 107–114

    PubMed  Google Scholar 

  75. Fine RL, Patel J, Chabner BA (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85: 582–586

    PubMed  Google Scholar 

  76. Fleischman LF, Chahwala SB, Cantley L (1986) Ras-transformed cells altered levels of phosphatidylinositol-4-5-bisphosphate and catabolites. Science 231: 407–410

    PubMed  Google Scholar 

  77. Forbes I, Zalewski P, Giannakis C, Cowled P (1992) Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 198: 367–372

    PubMed  Google Scholar 

  78. Fults D, Pedone CA, Thomas GA, White R (1990) Allelotype of human malignant astrocytomas. Cancer Res 50: 5784–5789

    PubMed  Google Scholar 

  79. Gillaspy GE, Mapstone TB, Samols D, Goldthwait DA (1992) Transcriptional patterns of growth factors and protooncogenes in human glioblastomas and normal glial cells. Cancer Lett 65: 55–60

    PubMed  Google Scholar 

  80. Glick RP, Unterman TG, Hollis R (1991) Radioimmunoassay of insulin-like growth factor in cyst fluid of central nervous system tumours. J Neurosurg 74: 972–978

    PubMed  Google Scholar 

  81. Gopalakrishna R, Barsky RH (1988) Tumour promotor-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA 85: 612–616

    PubMed  Google Scholar 

  82. Guillem JG, O'Brian CA, Fitzer CJ, Forde KA, LoGerfo P, Treat M, Weinstein IB (1987) Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. Cancer Res 47: 2036–2039

    PubMed  Google Scholar 

  83. Ha KS, Exton JH (1993) Different translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J Biol Chem 268: 10534–10539

    PubMed  Google Scholar 

  84. Hashimoto T, Ase K, Sawamura S, Kikkawa U, Saito N, Tanaka C, Nishizuka Y (1988) Postnatal development of brain-specific subspecies of protein kinase C in rat. J Neurosci 8: 1678–1638

    PubMed  Google Scholar 

  85. Hocevar BA, Fields AP (1991) Selective translocation of βII-protein kinase C to the nucleus of human promyelocytic (HL-60) leukemia cells. J Biol Chem 266: 28–33

    PubMed  Google Scholar 

  86. Honegger P (1986) Protein kinase C-activating tumour promotors enhance the differentiation of astrocytes in aggregating fetal brain cell cultures. J Neurochem 46: 1561–1566

    PubMed  Google Scholar 

  87. Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kishmeier P, Weinstein IB (1988) Overproduction of protein kinase C causes disordered growth on rat fibroblasts. Cell 52: 343–354

    PubMed  Google Scholar 

  88. Huang M, Chida K, Kamata N, Nose K, Kato M, Homma Y, Takenawa T, Kuroki T (1988) Enhancement of inositol phospholipid metabolism and activation of protein kinase C in rastransfromed rat fibroblasts. J Biol Chem 263: 17975–17980

    PubMed  Google Scholar 

  89. Ikemoto H, Tani E, Matsumoto T, Nakano A, Furuyama J (1995) Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor. J Neurosurg 83: 1008–1016

    PubMed  Google Scholar 

  90. Inoue M, Kishimoto A, Takai Y, Nishizua Y (1977) Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissue II. J Biol Chem 252: 7610–7616

    PubMed  Google Scholar 

  91. Iwasaki K, Toms SA, Barnett GH, Estes ML, Gupta MK, Barna BP (1995) Inhibitory effects of tamoxifen and tumour necrosis factor alpha on human glioblastoma cells. Cancer Immunol Immunother 40: 228–234

    PubMed  Google Scholar 

  92. James CD, Carlblom E, Dumanski JP, Hansen M, Nordensk-jold M, Collins VP, Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551

    PubMed  Google Scholar 

  93. Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S (1994) Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 54. 1707–1714

    PubMed  Google Scholar 

  94. Kanter P, Leister K, Tomei L, Wenner P, Wenner C (1984) Epidermal growth factor and tumour promotors prevent DNA fragmentation by different mechanisms. Biochem Biophys Res Commun 118: 392–399

    PubMed  Google Scholar 

  95. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257, 1972.

    PubMed  Google Scholar 

  96. Kikkawa U, Takai Y, Tanaka, Miyake R, Nishizuka Y (1982) Protein kinase C as a possible receptor protein of tumour-promoting phorbol esters. J Biol Chem 257: 7847–7851

    PubMed  Google Scholar 

  97. Kiley SC, Jaken S, Whelan R, Parker PJ (1995) Intracellular targeting of protein kinase C isoenzymes, functional implications. Biochem Soc Trans 23: 601–605

    PubMed  Google Scholar 

  98. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka SI, Tommaga M, Kuroda T, Nishizuka Y (1989) Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 264: 4088–4092

    PubMed  Google Scholar 

  99. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y (1980) Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273–2276

    PubMed  Google Scholar 

  100. Kiss Z, Deli E, Kuo JF (1988) Temporal changes in intracellular distribution of protein kinase C during differentiation of human leukemia HL 60 cells induced by phorbol ester. FGBS Lett 231: 41–46

    Google Scholar 

  101. Knox KA, Johnson GD, Gordon J (1993) A study of protein kinase C isoenzyme distribution in relation to Bcl-2 expression during apoptosis of ephitelial cells in vivo. Exp Cell Res 207: 68–73

    PubMed  Google Scholar 

  102. Koide H, Ogita K, Kikkawa U, Nishizuka Y (1992) Isolation and characterization of the epsilon subspecies of protein kinase C from rat brain. Proc Natl Acad Sci USA 89: 1149–1153

    PubMed  Google Scholar 

  103. Kolch W, Heldecker G, Kochs G, Hummel R, Vahldl H, Mischak H, Finkenzeller G, Marme D, Rapp UR (1993) Protein kinase Calpha activates Raf-1 by direct phosphorylation. Nature 364: 249–252

    PubMed  Google Scholar 

  104. Kopp R, Neolke B, Sauter G, Schildberg FW, Paumgartner G, Pfeiffer A (1991) Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 51: 205–210

    PubMed  Google Scholar 

  105. Lacal JC, Moscat J, Aaronson SA (1987) Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature 330: 269–272

    PubMed  Google Scholar 

  106. Lavin MF, Watters D, Song Q (1996) Role of protein kinase activity in apoptosis. Experientia 52: 979–994

    PubMed  Google Scholar 

  107. Lee SA, Karaszkiewicz JW, Anderson WB (1992) Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 52: 3750–3759

    PubMed  Google Scholar 

  108. Leibersperger H, Gschwendt M, Marks F (1990) Purification and characterization of a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase from porcine spleen. J Biol Chem 265: 16108–16115

    PubMed  Google Scholar 

  109. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1984) Amplification enhanced expression and possible rearrangement of EGF receptor in primary human brain tumors of glial origin. Nature 313: 144–147

    Google Scholar 

  110. Liyanage M, Frith D, Livneh E, Stabel S (1992) Protein kinase C group B members PKC-delta,-epsilon, -zeta and PKC-L (eta). Comparison of properties of recombinant proteins in vitro and in vivo. Biochem J 283: 781–787

    PubMed  Google Scholar 

  111. Ma L, Marquardt D, Takemoto L, Center MS (1991) Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593–5599

    PubMed  Google Scholar 

  112. Masliah E, Cole G, Shimohama S,et al (1990) Differential involvement of protein kinase C isozymes in Alzheimer's disease. J Neurosci 10: 2113–2124

    PubMed  Google Scholar 

  113. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades NH (1990) Coexpression of platelet-derved growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintainance. J Clin Invest 86: 131–140

    PubMed  Google Scholar 

  114. May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, Davidson NE (1994) Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis. J Biol Chem 269: 26865–26870

    PubMed  Google Scholar 

  115. McConkey D, Hartzell P, Jondal M, Orrenius S (1989) Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 264: 13399–13402

    PubMed  Google Scholar 

  116. Meisenhelder J, Suh P-G, Rhee SG, Hunter T (1989) Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57: 1109–1122

    PubMed  Google Scholar 

  117. Meyerson M, Enders GH, Wu CL, Su L-K, Gorka C, Nelson C, Harlow E, Tsai LH (1992) A family of human cdc2-related protein kinases. EMBO J 11: 2909–2917

    PubMed  Google Scholar 

  118. Mischak H, Goodnight J, Kolch W,et al (1993) Overexpression of protein kinase C-δ and ɛ in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumourigenicity. J Biol Chem 268: 6090–6096

    PubMed  Google Scholar 

  119. Misra-Press A, Fields AP, Samols D, Goldthwait DA (1992) Protein kinase C isoforms in human glioblastoma cells. GLIA 6: 188–197

    PubMed  Google Scholar 

  120. Missiaen L, Taylor CW, Berridge MJ (1991) Spontaneous calcium release from inositol trisphosphate-sensitive calcium stores. Nature 352: 241–244

    PubMed  Google Scholar 

  121. Miyamoto KI, Wakusawa S, Inoko K, Takagi K, Koyama M (1992) Reversal of vinblastine resistance by a new staurosporine derivate, NA-382 in P388/ADR cells. Cancer Lett 64: 177–183

    PubMed  Google Scholar 

  122. Mochly-Rosen D, Khaner H, Lopez J (1991) Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA 88: 3997–4000

    PubMed  Google Scholar 

  123. Morrison RS, Giordano S, Yamaguchi F, Hendrickson S, Berger MS, Palczewski K (1993) Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res 34: 502–509

    PubMed  Google Scholar 

  124. Murphy S, McCabe N, Morrow C, Pearce B (1987) Phorbol ester stimulates the proliferation of astrocytes in primary culture. Dev Brain Res 31: 133–135

    Google Scholar 

  125. Neary JT, Norenberg OB, Norenberg MD (1988) Protein kinase C in primary astrocyte cultures: cytoplasmic localization and translocation by a phorbol ester. J Neurochem 50: 1179–1184

    PubMed  Google Scholar 

  126. Niedler JE, Kuhn LJ, Vandenbark GR (1983) Phorbol diester receptor co-purifies with protein kinase C. Proc Natl Acad Sci USA 80: 36–40

    PubMed  Google Scholar 

  127. Nigg EA, Kreak W, Peter M (1991) Vertebrate cdc2 kinase: its regulation by phosphorylation and its mitotic targets. Cold Spring Harbor Symp Quant Biol 56: 539–547

    PubMed  Google Scholar 

  128. Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–695

    PubMed  Google Scholar 

  129. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665

    PubMed  Google Scholar 

  130. Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607–613

    PubMed  Google Scholar 

  131. Nister M, Claesson-Welch L, Eriksson A, Heldin C-H, West-ermark B (1991) Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem 266: 16755–16763

    PubMed  Google Scholar 

  132. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB (1985) Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2452–2465

    Google Scholar 

  133. O'Brian CA, Vogel VG, Singletary SE, Ward NE (1989) Elevated protein kinase C expression in human breast tumour biopsies relative to normal breast tissue. Cancer Res 49: 3215–3217

    PubMed  Google Scholar 

  134. Ogita K, Miyamoto S, Yamaguchi K, Koide H, Fujisawa N, Kikkawa U, Sahara S, Fukami Y, Nishizuka Y (1992) Isolation and characterization of delta-subspecies of protein kinase C from rat brain. Proc Natl Acad Sci USA 89: 1592–1596

    PubMed  Google Scholar 

  135. Ohgaki H, Schauble B, Zur Hausen A, Ammon K von, Kleihues P (1995) The role of transformation-associated genes in the evolution of astrocytic brain tumours. Virchows Arch 427: 113–118

    PubMed  Google Scholar 

  136. Olivier AR, Parker PJ (1994) Bombesin, platelet-derived growth factor, and diacylglycerol induce selective membrane association and down-regulation of protein kinase C isotypes in Swiss 3T3 cells. J Biol Chem 269: 2758–2763

    PubMed  Google Scholar 

  137. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y (1989) Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci USA 86: 3099–3103

    PubMed  Google Scholar 

  138. Orr JW, Kranen LM, Newton AC (1992) Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol. J Biol Chem 267: 15263–15266

    PubMed  Google Scholar 

  139. Osada SI, Mizuno K, Saido TC, Akita Y, Suzuki K, Kuroki T, Ohno S (1990) A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 265: 22434–22440

    PubMed  Google Scholar 

  140. Persons DA, Wilkinson WO, Bell RM, Finne OJ (1988) Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-1 cDNA. Cell 52: 447–458

    PubMed  Google Scholar 

  141. Pilkington GJ (1995) Mechanisms underlying local invasive behavior of brain tumours. Anticancer Res 15: 1675–1676

    Google Scholar 

  142. Pollack IF (1994) Current concepts in the diagnosis and treatment of pediatric brain tumors. New Engl J Med 331: 1500–1507

    PubMed  Google Scholar 

  143. Pollack IF, Kawecki S (1994) Patterns of growth factor, growth factor receptor, and second messenger expression in pediatric brain tumours. J Neurosurg 80: 400A

    Google Scholar 

  144. Pollack IF, Kawecki S (1994) Selective inhibition of protein kinase C abolishes glioma proliferation in vitro. Proceedings of the Congress of Neurological Surgeons Satellite Tumour Symposium, Chigago, Illinois, October 6–7, 1994

  145. Pollack IF, Kawecki S (1995) The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumours. Pediatr Neurosurg 22: 281–288

    PubMed  Google Scholar 

  146. Pollack IF, Kawecki S, Lazo IS (1996) Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor. J Neurosurg 84: 1024–1032

    PubMed  Google Scholar 

  147. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr (1990) Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J Neurosurg 73: 106–112

    PubMed  Google Scholar 

  148. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr (1990) Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. J Neurosurg 73: 98–105

    PubMed  Google Scholar 

  149. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr (1990) Effects of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 50: 7134–7138

    PubMed  Google Scholar 

  150. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr (1991) Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75: 284–293

    PubMed  Google Scholar 

  151. Pongracz J, Tuffley W, Johnson GD, Deacon EM, Burnett D, Stockley RA, Lord JM (1995) Changes in protein kinase C isoenzyme expression associated with apoptosis in U937 myelomonocytic cells. Exp Cell Res 218: 430–438

    PubMed  Google Scholar 

  152. Posada J, Vichi P, Tritton TR (1989) Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49: 6634–6639

    PubMed  Google Scholar 

  153. Preul MC, Villemure J-G, Langleben A, Bahary J-P, Shenouda G, LeBlanc R, Pokrupa R, Olivier A, Arnold D (1993) Biochemical effects of high-dose tamoxifen for recurrent malignant glioma monitored in vivo with 1H-MR spectroscopic imaging. J Neurosurg 80: 413A

    Google Scholar 

  154. Price BD, Morris JDH, Marshall CJ, Hall A (1989) Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation. J Biol Chem 264: 16638–16643

    PubMed  Google Scholar 

  155. Reifenberger G, Deckert M, Wechsler W (1989) Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumours. Acta Neuropathol 78: 166–175

    PubMed  Google Scholar 

  156. Rodriguez-Pena A, Rozengurt E (1984) Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys Res Commun 120: 1053–1059

    PubMed  Google Scholar 

  157. Rodriguez-Tarduchy G, Lopez-Rivas A (1989) Phorbol esters inhibit apoptosis in IL-2-dependent T lymphocytes. Biochem Biophys Res Commun 164: 1068–1075

    Google Scholar 

  158. Savart M, Letard P, Bultel S, Ducastaing A (1992) Induction of protein kinase C down-regulation by the phorbol ester TPA in a calpain/protein kinase C complex. Int J Cancer 52: 399–403

    PubMed  Google Scholar 

  159. Sawada M, Suzumura A, Ohno K, Marunochi T (1993) Regulation of astrocyte proliferation by prostaglandin E2 and the alpha subtype of protein kinase C. Brain Res 613: 67–73

    PubMed  Google Scholar 

  160. Schober R, Bilzer T, Waha A, Reifenberger G, Wechsler W, von Deimling A, Wiestler OD, Westphal M, Kemshead JT, Vega F,et al (1995) The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Clin Neuropathol 14: 169–174

    PubMed  Google Scholar 

  161. Schwartz GK, Redwood SM, Ohnuma T,et al (1990) Inhibition of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst 82: 1753–1756

    PubMed  Google Scholar 

  162. Seynaeve CM, Stetler-Stevenson M, Sebers S, Kaur G, Sausville EA, Worland PJ (1993) Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Cancer Res 53: 2081–2086

    PubMed  Google Scholar 

  163. Shimosawa S, Hachiya T, Hagiwara M,et al (1990) Type-specific expression of protein kinase C isozymes in human brain tumours. Neurosci Lett 108: 11–16

    PubMed  Google Scholar 

  164. Soderling TR (1990) Protein kinases. Regulation by autoinhibitory domains. J Biol Chem 265: 1823–1826

    PubMed  Google Scholar 

  165. Susa M, Olivier AR, Fabbro D, Thomas G (1989) EGF induces biphasic S6 kinase activation: late phase is protein kinase C-dependent and contributes to mitogenicity. Cell 57: 817–824

    PubMed  Google Scholar 

  166. Takai Y, Kishimoto A, Inoue M, Nishizuka Y (1977) Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissue. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 252: 7603–7609

    PubMed  Google Scholar 

  167. Todo T, Shitara N, Nakamura H, Takakura K, Ikeda K (1991) Immunohistochemical demonstration of protein kinase C isozymes in human brain tumours. Neurosurgery 29: 399–404

    PubMed  Google Scholar 

  168. Tomei L, Kanter P, Wenner C (1988) Inhibition of radiation-induced apoptosis in vitro by tumour promoters. Biochem Biophys Res Commun 155: 324–331

    PubMed  Google Scholar 

  169. Uhm JH, Dooley NP, Villemure JG, Yong VW (1996) Glioma invasion in vitro — regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 14: 421–433

    PubMed  Google Scholar 

  170. van der Valk P, de Moor I, Kamphorst W, Meijer CJ (1995) Autocrine and paracrine growth in gliomas. J Pathol 175 [Suppl]: 106A

    Google Scholar 

  171. Vassbotn FS, Ostman A, Langeland N, Holmsen H, Westermark B, Heldin CH, Nister M (1994) Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J Cell Physiol 158: 381–389

    PubMed  Google Scholar 

  172. Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, Noble MD (1991) Retinoblastoma gene deletions in human glioblastomas. Oncogene 6: 445–448

    PubMed  Google Scholar 

  173. Vertosick FT Jr, Selker RG (1993) Dose escalation trials of oral tamoxifen in the treatment of newly diagnosed and recurrent glioblastoma multiforme. Proc Annu Meet Am Assoc Canc Res 34 (abstract)

  174. Vertosick FT Jr, Selker RG, Pollack IF, Arena V (1992) The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of “failed” patients. Neurosurgery 30: 897–903

    PubMed  Google Scholar 

  175. Ward NE, O'Brian CA (1991) Distinct patterns of phorbol ester-induced down-regulation of protein kinase C activity in adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells. Cancer Lett 58: 189–193

    PubMed  Google Scholar 

  176. Ways DK, Cook PP, Webster C, Parker PJ (1992) Effects of phorbol esters on protein kinase C-zeta. J Biol Chem 267: 4799–4805

    PubMed  Google Scholar 

  177. Werner MH, Humphrey PA, Bigner DD, Bigner SH (1988) Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol 77: 196–201

    PubMed  Google Scholar 

  178. Westphal M, Brunken M, Rohde E, Herrmann H-D (1988) Growth factors in cultured human glioma cells: different effects of FGF, EGF, and PDGF. Canc Lett 38: 283–296

    Google Scholar 

  179. Wolfman A, Macara IG (1987) Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 325: 359–361

    PubMed  Google Scholar 

  180. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899–8903

    PubMed  Google Scholar 

  181. Yamanishi DT, Graham M, Buckmeier JA, Meykens FL (1991) The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis 12: 105–109

    PubMed  Google Scholar 

  182. Yazaki T, Ahmad S, Chahlavi A, Zylberkatz E, Dean NM, Rabkin SD, Martuza RL, Glazer RI (1996) Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α-phosphorothioate oligodeoxynucleotide. Molec Pharmacol 50: 236–242

    Google Scholar 

  183. Yong VW (1992) Proliferation of human and mouse astrocytes in vitro: signaling through the protein kinase C pathway. J Neurol Sci 111: 92–103

    PubMed  Google Scholar 

  184. Young JL, Miller RW (1975) Incidence of malignant tumours in United States children. J Pediatr 86: 254–258

    PubMed  Google Scholar 

  185. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Cowan KH, Glazer RI (1991) Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 3: 181–189

    PubMed  Google Scholar 

  186. Zhang W, Law RE, Hinton DR, Su Y, Couldwell WT (1995) Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C. Cancer Lett 96: 31–35

    PubMed  Google Scholar 

  187. Zhu WH, Loh TT (1996) Differential effects of phorbol ester on apoptosis in HL-60 promyelocytic leukemia cells. Biochem Pharmacol 51: 1229–1236

    PubMed  Google Scholar 

  188. Zong Z, Fujikawa-Yamamoto K, Tanino M, Teraoka K, Yamagishi H, Odashima S (1996) Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Biochem Biophys Res Commun 219: 480–485

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    M. Bredel & I. F. Pollack M.D.

  2. University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, PA, USA

    M. Bredel & I. F. Pollack M.D.

Authors
  1. M. Bredel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. F. Pollack M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bredel, M., Pollack, I.F. The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy. Acta neurochir 139, 1000–1013 (1997). https://doi.org/10.1007/BF01411552

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01411552

Keywords

Search

Navigation